MPS. Pharma-Europe SRL
Ouverture de failliteMPS. Pharma-Europe reported total assets of 20,160 € at the end of the 2021 financial year (annual accounts filed with the NBB on 21 Feb 2022).
The score of MPS. Pharma-Europe shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2021
Change 2018 → 2021: Equity -79 % Total assets -66 %
Accounts of the company itself (not consolidated).
The full file covers 6 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MPS. Pharma-Europe's annual accounts
Filed annual accounts
- Year ended 30 Jun 2021filed on 21 Feb 2022
- Year ended 30 Jun 2020filed on 13 Feb 2021
- Year ended 30 Jun 2019filed on 16 Jan 2020
- Year ended 30 Jun 2018filed on 06 Feb 2019
- Year ended 30 Jun 2017filed on 20 Aug 2018
MPS. Pharma-Europe's financial analysis
- Solvency57.2%sector median: 48.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MPS. Pharma-Europe
MPS. Pharma-Europe's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0831.669.288
- VAT number
- BE0831669288
- Peppol
- Not found on Peppol as of 12 Nov 2026 · Check
- Legal form
- SRL
- Incorporated
- 06 Dec 2010
- Registered office
- 2610 Antwerp
- Latest accounts
- 2021 · filed on 21 Feb 2022
- Activity
- General work of electrical installation (NACE 43211)
MPS. Pharma-Europe (SRL) has been based in Antwerp since 2010, active in: general work of electrical installation. For 2021, it reports a net loss of 32,410 € and equity of 11,531 €; its revenue is not published. Its solvency stands at 57.2%, above the median of its sector (48.5%).
Guide: How to check a Belgian building contractor before works →
Companies similar to MPS. Pharma-Europe
Companies in the same business, of comparable size and area, outside its group.
- Thobo Electrics Electrical installation Lille · balance sheet 74,790 €
- LP Electricite Manufacture of electric motors, generators and transformers Assesse · balance sheet 185,871 €
- Guedoura Electrical installation Antwerp · balance sheet 208,893 €
- Tecame Belgium Manufacture of electric motors, generators and transformers La Bruyère · balance sheet 176,444 €
- Vadatech Electrical installation Berlare · balance sheet 182,791 €
- Elthium Manufacture of electric motors, generators and transformers Kortenberg · balance sheet 247,889 €
- A Sunny Future Electrical installation Dendermonde · balance sheet 374,300 €
- Stellow Electrical installation Kalmthout · balance sheet 975,949 €
Frequently asked questions about MPS. Pharma-Europe
What is the revenue of MPS. Pharma-Europe?
MPS. Pharma-Europe files its accounts in a format where revenue is optional: it is not published for 2021.
What is the VAT number of MPS. Pharma-Europe?
In Belgium, the VAT number is the company number prefixed with BE: BE0831669288 for MPS. Pharma-Europe, if the company is VAT-registered. Its company number (CBE) is 0831.669.288.
Where is the registered office of MPS. Pharma-Europe?
According to the CBE register, the registered office of MPS. Pharma-Europe is in 2610 Antwerp.
What is the equity of MPS. Pharma-Europe?
At the close of the 2021 financial year, the equity of MPS. Pharma-Europe amounts to 11,531 €, a solvency of 57.2% of total assets.
Who manages MPS. Pharma-Europe?
The register lists 2 active mandates at MPS. Pharma-Europe. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MPS. Pharma-Europe
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →